Atai Life Sciences N.V. (NQ: ATAI )
1.330
+0.010
(+0.76%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
All News about Atai Life Sciences N.V.![]() ![]() ![]() ![]()
Use of Ketamine for Mental Disorders Rising While New Therapies Emerge
November 17, 2021
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Ketamine’s Potential As A Treatment For Depression Has Drawn Major Industry Attention
October 27, 2021
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]() ![]()
NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Bringing Therapeutic Options to Diseases with Unmet Needs
September 30, 2021
Topics
Cannabis
Exposures
Cannabis
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|